Cytoplasmic expression and specific binding of the VH/VL single domain intrabodies in transfected NIH3T3 cells

Experimental and Molecular Pathology

Volumn 86, Issue 1, 2009, Pages 51-56

  Sawahata, Ryoko ^a   Sato, Mitsuru ^a   Kitani, Hiroshi ^a  

^a NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

Author keywords

Cytoplasmic expression; Intrabody; Single domain; VH and VL

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN;

ANIMAL CELL; ANTIBODY COMBINING SITE; ANTIGEN BINDING; ARTICLE; CELL STRAIN 3T3; GENE CONSTRUCT; GENE SEQUENCE; GENETIC TRANSFECTION; IMMUNOGLOBULIN VARIABLE REGION; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTIBODIES; CYTOPLASM; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MICE; NIH 3T3 CELLS; TRANSFECTION; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 59249109320     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2008.11.005     Document Type: Article

References (24)

1. Alvarez R.D., Barnes M.N., Gomez-Navarro J., Wang M., Strong T.V., Arafat W., Arani R.B., Johnson M.R., Roberts B.L., Siegal G.P., and Curiel D.T. A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. Clin. Cancer Res. 6 (2000) 3081-3087
2. Bird R.E., Hardman K.D., Jacobson J.W., Johnson S., Kaufman B.M., Lee S.M., Lee T., Pope S.H., Riordan G.S., and Whitlow M. Single-chain antigen-binding proteins. Science 242 (1988) 423-426
3. Caron de Fromentel C., Gruel N., Venot C., Debussche L., Conseiller E., Dureuil C., Teillaud J.L., Tocque B., and Bracco L. Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragments. Oncogene 18 (1999) 551-557
4. Cattaneo A., and Biocca S. The selection of intracellular antibodies. Trends Biotechnol. 17 (1999) 115-121
5. Colby D.W., Garg P., Holden T., Chao G., Webster J.M., Messer A., Ingram V.M., and Wittrup K.D. Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display. J. Mol. Biol. 342 (2004) 901-912
6. Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Songa E.B., Bendahman N., and Hamers R. Naturally occurring antibodies devoid of light chains. Nature 363 (1993) 446-448
7. Holt L.J., Herring C., Jespers L.S., Woolven B.P., and Tomlinson I.M. Domain antibodies: proteins for therapy. Trends Biotechnol. 21 (2003) 484-490
8. Huston J.S., Levinson D., Mudgett-Hunter M., Tai M.S., Novotny J., Margolies M.N., Ridge R.J., Bruccoleri R.E., Haber E., Crea R., and Oppermann H. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 5879-5883
9. Lobato M.N., and Rabbitts T.H. Intracellular antibodies and challenges facing their use as therapeutic agents. Trends Mol. Med. 9 (2003) 390-396
10. Marasco W.A., Haseltine W.A., and Chen S.Y. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7889-7893
11. Molina I.J., Sancho J., Terhorst C., Rosen F.S., and Remold-O'Donnell E. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J. Immunol. 151 (1993) 4383-4390
12. Niwa H., Yamamura K., and Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108 (1991) 193-199
13. Ochs H.D., Slichter S.J., Harker L.A., Von Behrens W.E., Clark R.A., and Wedgwood R.J. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood 55 (1980) 243-252
14. Oosterhoff D., Pinedo H.M., van der Meulen I.H., de Graaf M., Sone T., Kruyt F.A., van Beusechem V.W., Haisma H.J., and Gerritsen W.R. Secreted and tumour targeted human carboxylesterase for activation of irinotecan. Br. J. Cancer 87 (2002) 659-664
15. Remold-O'Donnell E., Rosen F.S., and Kenney D.M. Defects in Wiskott-Aldrich syndrome blood cells. Blood 87 (1996) 2621-2631
16. Sato M., Tsuji N.M., Gotoh H., Yamashita K., Hashimoto K., Tadotsu N., Yamanaka H., Sekikawa K., and Hashimoto Y. Overexpression of the Wiskott-Aldrich syndrome protein N-terminal domain in transgenic mice inhibits T cell proliferative responses via TCR signaling without affecting cytoskeletal rearrangements. J. Immunol. 167 (2001) 4701-4709
17. Sato M., Iwaya R., Ogihara K., Sawahata R., Kitani H., Chiba J., Kurosawa Y., and Sekikawa K. Intrabodies against the EVH1 domain of Wiskott-Aldrich syndrome protein inhibit T cell receptor signaling in transgenic mice T cells. FEBS J. 272 (2005) 6131-6144
18. Snapper S.B., Rosen F.S., Mizoguchi E., Cohen P., Khan W., Liu C.H., Hagemann T.L., Kwan S.P., Ferrini R., Davidson L., Bhan A.K., and Alt F.W. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 9 (1998) 81-91
19. Steinberger P., Andris-Widhopf J., Buhler B., Torbett B.E., and Barbas III C.F. Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 805-810
20. Takemoto Y., Furuta M., Sato M., and Hashimoto Y. A simple improvement in expression cloning. DNA Cell Biol. 16 (1997) 797-799
21. Takemoto Y., Furuta M., Sato M., Kubo M., and Hashimoto Y. Isolation and characterization of a novel HS1 SH3 domain binding protein, HS1BP3. Int. Immunol. 11 (1999) 1957-1964
22. Tanaka T., and Rabbitts T.H. Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation. EMBO J. 22 (2003) 1025-1035
23. Tanaka T., and Rabbitts T.H. Functional intracellular antibody fragments do not require invariant intra-domain disulfide bonds. J. Mol. Biol. 376 (2008) 749-757
24. Zhang J., Shehabeldin A., da Cruz L.A., Butler J., Somani A.K., McGavin M., Kozieradzki I., dos Santos A.O., Nagy A., Grinstein S., Penninger J.M., and Siminovitch K.A. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J. Exp. Med. 190 (1999) 1329-1342